Edal, Almira .

HRN: 17-96-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/28/2023
09/28/2023
IV
2.25g
Q8H
CAP MR; Presumptive PTB
Checking Final Appropriateness 
09/28/2023
AZITHROMYCIN 500MG TABLET (TAB)
09/28/2023
10/05/2023
PO
500mg
OD
CAP MR
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: